AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#425 today
$403.04
-1.04% today · -2.79% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- AMGN −1.04% on the last session vs SPY +0.74%: −1.8 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 72 big drops in the past 5 years, AMGN typically gained 0.8% over the next month (median) and was higher 56% of the time; half the outcomes fell between -3.8% and +6.3%. An ordinary month: +0.9%. Among S&P 500 stocks after big drops, that ranks #393 of 500.
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
AMGN against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #425 | -1.04% | +0.74% | |
| 1 week | #373 | -2.79% | -0.22% | |
| 1 month | #369 | -8.99% | +0.84% | |
| 3 months | #103 | +8.35% | +3.59% | |
| 6 months | #138 | +17.39% | +17.95% | |
| 1 year | #84 | +39.28% | +16.25% | |
| Overall | #235 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Drug Manufacturers - General
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | -0.01 | #473 | #9 |
| fPE/tPE | 0.66 | #157 | #6 |
| PE/G | 2.43 | #392 | #5 |
| EV/Revenue | 6.86 | #123 | #3 |
| Gross Margin | 0.72 | #75 | #7 |
| Profit Margin | 0.23 | #117 | #2 |
| Revenue Growth | 0.10 | #242 | #4 |